Japanese Red Cross Nagoya Daiichi Hospital

Nagoya, Aichi-ken 453-8511

0 studies enrolling now · 2 studies all time

What they study most

Non-Small Cell Lung Cancer, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) — Completed